BRIEF published on 09/03/2026 at 16:06, 1 month 27 days ago The Vanguard Group Discloses Position in Schroders plc Form 8.3 Securities Disclosure Schroders Plc Vanguard Group Share Dealings
BRIEF published on 09/03/2026 at 16:06, 1 month 27 days ago The Vanguard Group Discloses Position in Tate & Lyle plc Disclosure Takeover Code Vanguard Group Securities Position Tate & Lyle
BRIEF published on 09/03/2026 at 16:06, 1 month 27 days ago The Vanguard Group Discloses Position in Spire Healthcare Group The Vanguard Group Takeover Code Spire Healthcare Form 8.3 Disclosure Shareholdings
BRIEF published on 09/03/2026 at 16:04, 1 month 27 days ago The Vanguard Group, Inc.: Disclosure on SEGRO plc Disclosure The Vanguard Group Takeover Code Share Transactions SEGRO PLC
BRIEF published on 09/03/2026 at 16:04, 1 month 27 days ago The Vanguard Group Discloses Position in LondonMetric Property Form 8.3 Takeover Code Vanguard Group LondonMetric Property Schroder Real Estate
PRESS RELEASE published on 09/03/2026 at 16:03, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.00% ownership in Beazley plc with recent dealings in 5p ordinary securities Vanguard Group Ownership Disclosure Dealings Beazley Plc 5p Ordinary Securities
PRESS RELEASE published on 09/03/2026 at 16:02, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Rotork plc The Vanguard Group, Inc. discloses 5.46% stake in Rotork plc on 02/09/2026. Purchases 44,722 Rotork plc securities The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Securities Purchase Rotork Plc
PRESS RELEASE published on 09/03/2026 at 16:01, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses 2.72% stake in Schroders plc as of 02 Sep 2026. Details in Form 8.3 per Takeover Code Rule 8.3 Form 8.3 Disclosure Takeover Code Schroders Plc Vanguard Group
PRESS RELEASE published on 09/03/2026 at 16:01, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.78% stake in Tate & Lyle plc. Form 8.3 filing under Takeover Code rules. Details of securities and dealings provided Form 8.3 Dealing Disclosure Securities Disclosure Vanguard Group Tate & Lyle Plc
PRESS RELEASE published on 09/03/2026 at 16:01, 1 month 27 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.57% interest in Spire Healthcare Group plc. Purchase of 1,470 securities at 2.36 GBP per unit disclosed The Vanguard Group Securities Purchase Spire Healthcare Group Plc 3.57% Interest 2.36 GBP Per Unit
Published on 10/30/2026 at 23:35, 1 day 1 hour ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 1 day 1 hour ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 19:00, 1 day 6 hours ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day 9 hours ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/31/2026 at 16:35, 8 hours 53 minutes ago SKYWORTH Solar Announces Global Launch of Solavita as a Smart Microgrid Brand
Published on 10/30/2026 at 22:49, 1 day 2 hours ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 1 day 6 hours ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 1 day 2 hours ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 12:00, 1 day 13 hours ago Capital increase through exercise of subscription rights
